Full Text View
Tabular View
No Study Results Posted
Related Studies
Pediatric Arthritis Study of Certolizumab Pegol (PASCAL)
This study is currently recruiting participants.
Verified April 2013 by UCB, Inc.
Study NCT01550003   Information provided by UCB, Inc.

First Received on March 7, 2012.   Last Updated on April 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Juvenile Idiopathic Arthritis (JIA)
Additional conditions recognized in this trial
Arthritis
Arthritis, Juvenile Rheumatoid
More general conditions related to this trial
Arthritis, Rheumatoid
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Certolizumab Pegol (CZP)
Additional drug interventions recognized in this trial
Immunoglobulin Fab Fragments
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
UCB BIOSCIENCES GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services